Literature DB >> 17513809

Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?

Astrid H Liavaag1, Anne Dørum, Sophie D Fosså, Claes Tropé, Alv A Dahl.   

Abstract

PURPOSE: There are few studies of somatic and mental morbidity in epithelial ovarian cancer survivors (EOCSs). The aim of this controlled, cross-sectional study was to explore fatigue, quality of life (QOL), and somatic and mental morbidity in EOCSs. PATIENTS AND METHODS: Among 287 EOCSs treated according to protocols at The Norwegian Radium Hospital between 1977 and 2003, 189 patients (66%) participated. Information was collected by a questionnaire containing demographic and morbidity items and self-rating scales. Internal comparisons of various subgroups of EOCSs were performed, and EOCSs were compared with age-adjusted controls from the general population.
RESULTS: Minimal differences were observed relating to somatic and mental morbidity, fatigue, and QOL between EOCSs with and without relapse, long or short follow-up time, and prognostic index status. Chronic fatigue was found in 22% (95% CI, 16% to 28%), and only body image was significantly associated with chronic fatigue in multivariable analyses. EOCSs showed significantly more somatic and mental morbidity, somatic complaints, use of medications, and use of health care services than controls. The levels of anxiety and fatigue were also significantly higher in EOCSs than in controls, whereas the levels of depression and of several QOL dimensions were lower. The prevalence of chronic fatigue was 12% among controls.
CONCLUSION: EOCSs had more somatic and mental morbidity, more fatigue, poorer QOL, and used more medication and health services than controls. Minimal differences were observed between various EOCS subgroups. Health care professionals should try to improve and be attentive to the health of EOCSs.

Entities:  

Mesh:

Year:  2007        PMID: 17513809     DOI: 10.1200/JCO.2006.09.1769

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  18 in total

1.  "The impact of cancer scale" version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors.

Authors:  Alv A Dahl; Saevar Berg Gudbergsson; Anne Dørum; Sophie D Fosså; Astrid H Liavaag; Øystein Sørebø
Journal:  Qual Life Res       Date:  2011-11-02       Impact factor: 4.147

2.  Survivorship care planning after participation in communication skills training intervention for a consultation about lymphoma survivorship.

Authors:  Smita C Banerjee; Matthew J Matasar; Carma L Bylund; Steven Horwitz; Kara McLarney; Tomer Levin; Paul B Jacobsen; Patricia Parker; Alan Astrow; David W Kissane
Journal:  Transl Behav Med       Date:  2015-06-02       Impact factor: 3.046

3.  Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer.

Authors:  Michaela G Cuneo; Andrew Schrepf; George M Slavich; Premal H Thaker; Michael Goodheart; David Bender; Steve W Cole; Anil K Sood; Susan K Lutgendorf
Journal:  Psychoneuroendocrinology       Date:  2017-06-30       Impact factor: 4.905

4.  Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors.

Authors:  Fay J Hlubocky; Christopher K Daugherty; Jeffery Peppercorn; Karen Young; Kristen E Wroblewski; Seiko Diane Yamada; Nita K Lee
Journal:  JCO Clin Cancer Inform       Date:  2022-08

5.  Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics.

Authors:  Christelle Schofield; Robert U Newton; Paul A Cohen; Daniel A Galvão; Joanne A McVeigh; Ganendra R Mohan; Jason Tan; Stuart G Salfinger; Leon M Straker; Carolyn J Peddle-McIntyre
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

6.  Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Karen M Gil; Heidi E Gibbons; Bradley J Monk; Peter G Rose; Deborah K Armstrong; David Cella; Lari Wenzel
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

Review 7.  Quality-of-life issues in the management of epithelial ovarian cancer.

Authors:  Thomas Lowe; Betty Ferrell; Lucille Leong
Journal:  Curr Treat Options Oncol       Date:  2007-12

Review 8.  Ovarian cancer survivors' quality of life: a systematic review.

Authors:  D Ahmed-Lecheheb; F Joly
Journal:  J Cancer Surviv       Date:  2016-02-17       Impact factor: 4.442

9.  The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

Authors:  Margaret F Bevans; Sandra A Mitchell; Susan Marden
Journal:  Support Care Cancer       Date:  2008-03-06       Impact factor: 3.603

10.  Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study.

Authors:  Roger T Anderson; Lauren C Peres; Fabian Camacho; Elisa V Bandera; Ellen Funkhouser; Patricia G Moorman; Lisa E Paddock; Edward S Peters; Sarah E Abbott; Anthony J Alberg; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ann G Schwartz; Paul Terry; Joellen M Schildkraut
Journal:  J Womens Health (Larchmt)       Date:  2018-10-10       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.